This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Welch, P. J. Articles by Hamdan, M. H. Search for Related Content PubMed PubMed Citation Articles by Welch, P. J. Articles by Hamdan, M. H.

Management of ventricular arrhythmias

A trial-based approach

^a Section of Clinical Cardiac Electrophysiology, Department of Internal Medicine (Cardiology Division), The University of Texas Southwestern Medical Center, Dallas, Texas, USA
^b The Dallas Veterans Affairs Medical Center, Dallas, Texas, USA

View larger version (25K): [in a new window]   Figure 1 Kaplan-Meier survival curves for post-MI patients cross-classified by ejection fraction (EF, <30% or over) and presence or absence of nonsustained VT. (Reprinted from American Journal of Cardiology 1986;58:1151–60, with permission from Excerpta Medica, Inc.)

View larger version (15K): [in a new window]   Figure 2 Survival without subsequent arrhythmia in patients with coronary artery disease and nonsustained VT, who had negative electrophysiology studies. Adapted from references 21–23 and 50.

View larger version (15K): [in a new window]   Figure 3 Arrhythmic events in patients with coronary artery disease and nonsustained VT who had positive EP studies. The patients with non-EP-guided therapy often had persistently inducible VT after one or more drug trials. Adapted from references 21, 23 and 50.